185 related articles for article (PubMed ID: 30024551)
1. Accuracy of 11C-choline positron emission tomography in differentiating glioma recurrence from radiation necrosis: A systematic review and meta-analysis.
Gao L; Xu W; Li T; Zheng J; Chen G
Medicine (Baltimore); 2018 Jul; 97(29):e11556. PubMed ID: 30024551
[TBL] [Abstract][Full Text] [Related]
2. Comparison of (11)C-methionine, (11)C-choline, and (18)F-fluorodeoxyglucose-PET for distinguishing glioma recurrence from radiation necrosis.
Takenaka S; Asano Y; Shinoda J; Nomura Y; Yonezawa S; Miwa K; Yano H; Iwama T
Neurol Med Chir (Tokyo); 2014; 54(4):280-9. PubMed ID: 24305028
[TBL] [Abstract][Full Text] [Related]
3. Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery--in malignant glioma.
Tsuyuguchi N; Takami T; Sunada I; Iwai Y; Yamanaka K; Tanaka K; Nishikawa M; Ohata K; Torii K; Morino M; Nishio A; Hara M
Ann Nucl Med; 2004 Jun; 18(4):291-6. PubMed ID: 15359921
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of
Yu J; Zheng J; Xu W; Weng J; Gao L; Tao L; Liang F; Zhang J
World Neurosurg; 2018 Jun; 114():e1211-e1224. PubMed ID: 29625311
[TBL] [Abstract][Full Text] [Related]
5. Clinical usefulness of 11C-MET PET and 201T1 SPECT for differentiation of recurrent glioma from radiation necrosis.
Sonoda Y; Kumabe T; Takahashi T; Shirane R; Yoshimoto T
Neurol Med Chir (Tokyo); 1998 Jun; 38(6):342-7; discussion 347-8. PubMed ID: 9689817
[TBL] [Abstract][Full Text] [Related]
6. Potential for differentiation of glioma recurrence from radionecrosis using integrated
Sogani SK; Jena A; Taneja S; Gambhir A; Mishra AK; D'Souza MM; Verma SM; Hazari PP; Negi P; Jadhav GK
Neurol India; 2017; 65(2):293-301. PubMed ID: 28290392
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and grading accuracy of
Xiao J; Jin Y; Nie J; Chen F; Ma X
BMC Cancer; 2019 Aug; 19(1):767. PubMed ID: 31382920
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Accuracy of Amino Acid and FDG-PET in Differentiating Brain Metastasis Recurrence from Radionecrosis after Radiotherapy: A Systematic Review and Meta-Analysis.
Li H; Deng L; Bai HX; Sun J; Cao Y; Tao Y; States LJ; Farwell MD; Zhang P; Xiao B; Yang L
AJNR Am J Neuroradiol; 2018 Feb; 39(2):280-288. PubMed ID: 29242363
[TBL] [Abstract][Full Text] [Related]
9. Glioma Recurrence Versus Radiation Necrosis: Single-Session Multiparametric Approach Using Simultaneous O-(2-18F-Fluoroethyl)-L-Tyrosine PET/MRI.
Jena A; Taneja S; Gambhir A; Mishra AK; Dʼsouza MM; Verma SM; Hazari PP; Negi P; Jhadav GK; Sogani SK
Clin Nucl Med; 2016 May; 41(5):e228-36. PubMed ID: 26859208
[TBL] [Abstract][Full Text] [Related]
10. 11C-MET PET/CT and advanced MRI in the evaluation of tumor recurrence in high-grade gliomas.
D'Souza MM; Sharma R; Jaimini A; Panwar P; Saw S; Kaur P; Mondal A; Mishra A; Tripathi RP
Clin Nucl Med; 2014 Sep; 39(9):791-8. PubMed ID: 25036022
[TBL] [Abstract][Full Text] [Related]
11. Performance of SPECT in the differential diagnosis of glioma recurrence from radiation necrosis.
Zhang H; Ma L; Wu C; Xu BN
J Clin Neurosci; 2015 Feb; 22(2):229-37. PubMed ID: 25443083
[TBL] [Abstract][Full Text] [Related]
12. A meta-analysis comparing 18F-FLT PET with 18F-FDG PET for assessment of brain tumor recurrence.
Li Z; Yu Y; Zhang H; Xu G; Chen L
Nucl Med Commun; 2015 Jul; 36(7):695-701. PubMed ID: 25768337
[TBL] [Abstract][Full Text] [Related]
13. Role of magnetic resonance spectroscopy for the differentiation of recurrent glioma from radiation necrosis: a systematic review and meta-analysis.
Zhang H; Ma L; Wang Q; Zheng X; Wu C; Xu BN
Eur J Radiol; 2014 Dec; 83(12):2181-2189. PubMed ID: 25452098
[TBL] [Abstract][Full Text] [Related]
14. PET/CT with (11)C-choline for evaluation of prostate cancer patients with biochemical recurrence: meta-analysis and critical review of available data.
Fanti S; Minozzi S; Castellucci P; Balduzzi S; Herrmann K; Krause BJ; Oyen W; Chiti A
Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):55-69. PubMed ID: 26450693
[TBL] [Abstract][Full Text] [Related]
15. Differential diagnosis between radiation necrosis and glioma progression using sequential proton magnetic resonance spectroscopy and methionine positron emission tomography.
Nakajima T; Kumabe T; Kanamori M; Saito R; Tashiro M; Watanabe M; Tominaga T
Neurol Med Chir (Tokyo); 2009 Sep; 49(9):394-401. PubMed ID: 19779283
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of the diagnostic performance of diffusion magnetic resonance imaging with apparent diffusion coefficient measurements for differentiating glioma recurrence from pseudoprogression.
Yu Y; Ma Y; Sun M; Jiang W; Yuan T; Tong D
Medicine (Baltimore); 2020 Jun; 99(23):e20270. PubMed ID: 32501974
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic efficacy of 18F-FDG-PET or PET/CT in breast cancer with suspected recurrence: a systematic review and meta-analysis.
Xiao Y; Wang L; Jiang X; She W; He L; Hu G
Nucl Med Commun; 2016 Nov; 37(11):1180-8. PubMed ID: 27428888
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic Accuracy of Centrally Restricted Diffusion in the Differentiation of Treatment-Related Necrosis from Tumor Recurrence in High-Grade Gliomas.
Zakhari N; Taccone MS; Torres C; Chakraborty S; Sinclair J; Woulfe J; Jansen GH; Nguyen TB
AJNR Am J Neuroradiol; 2018 Feb; 39(2):260-264. PubMed ID: 29217742
[TBL] [Abstract][Full Text] [Related]
19. Clinical impact of (11)C-methionine PET on expected management of patients with brain neoplasm.
Yamane T; Sakamoto S; Senda M
Eur J Nucl Med Mol Imaging; 2010 Apr; 37(4):685-90. PubMed ID: 19915838
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic accuracy of diffusion MRI with quantitative ADC measurements in differentiating glioma recurrence from radiation necrosis.
Zhang H; Ma L; Shu C; Wang YB; Dong LQ
J Neurol Sci; 2015 Apr; 351(1-2):65-71. PubMed ID: 25748965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
